USD 5.07 billion
Compounding Chemotherapy Market Size, Share, Growth Analysis, By Drug(Cytotoxic Drugs, Hormonal Agents, Immunomodulatory agents, Targeted Therapies), By Dose(Chemotherapeutic, and Non-Chemotherapeutics), By Delivery method(Gravimetric Automated Compounding Devices, and Volumetric Automated Compounding Devices), By Sterility(Sterile, and Non-Sterile), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2813 |
Region:
Global |
Published Date: July, 2024
Pages:
219
|Tables:
142
|Figures:
72
Compounding Chemotherapy Market Insights
Global Compounding Chemotherapy Market size was valued at USD 5.07 billion in 2022 and is poised to grow from USD 5.33 billion in 2023 to USD 7.92 billion by 2031, growing at a CAGR of 5.08% in the forecast period (2024-2031).
The global compounding chemotherapy market is witnessing significant expansion driven by several key factors. The increasing incidences of cancer and the continuous advancements in pharmaceutical compounding technologies play pivotal roles in fueling market growth. The rising geriatric population, more susceptible to cancer, further contributes to the expanding market as personalized treatment becomes increasingly vital.
Despite these growth drivers, the market faces certain constraints, including stringent regulatory requirements and safety concerns associated with compounding chemotherapy, underscoring the importance of compliance and patient safety. Conversely, there are promising opportunities on the horizon, such as the ongoing development of innovative compounding technologies and the increasing adoption of precision medicine approaches.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Chemotherapeutic
Fastest Growth
Chemotherapeutic
Growth Rate
5.08% CAGR
Global Compounding Chemotherapy Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Compounding Chemotherapy Market Segmental Analysis
Global Compounding Chemotherapy Market is segmented based on drug, dose, delivery method, sterility, and region. Based on drug, the market is segmented into cytotoxic drugs, hormonal agents, immunomodulatory agents, targeted therapies, and supportive care drugs. Based on dose, the market is segmented into Chemotherapeutic and Non-Chemotherapeutics. Based on delivery methods, the market is segmented into gravimetric automated compounding devices and volumetric automated compounding devices. Based on sterlity, the market is segmented into Sterile and Non-Sterile. Based on region, the market is segmented into North America, Euorpe, Asia Pacific, Latin America, Middle East & Africa.
Analysis by Dose
In the compounding chemotherapy market data for 2023, the chemotherapeutic segment emerged as the dominant force, holding the majority share. The prominence of the chemotherapeutic segment can be attributed to the greater effectiveness of chemotherapeutic medicines, which is a significant factor propelling the overall expansion of the market. These medications play a crucial role in cancer treatment, and their efficacy contributes substantially to their market dominance. Additionally, key drivers for the development and growth of this market include the aging population and the increasing incidence of cancer.
The non-chemotherapeutics segment plays a significant role in the compounding chemotherapy market by offering a diversified range of medications beyond traditional chemotherapeutic drugs. This segment encompasses various therapeutic agents such as supportive care medications, antiemetics, pain management drugs, and other pharmaceuticals aimed at mitigating side effects and enhancing overall patient well-being during cancer treatment. The inclusion of Non-Chemotherapeutics in compounding chemotherapy allows for a more comprehensive and tailored approach to patient care, addressing not only the primary cancer treatment but also the associated challenges and symptoms.
Global Compounding Chemotherapy Market By Dose
To get detailed analysis on other segments, Request For Free Sample Report
Compounding Chemotherapy Market Regional Insights
In 2023, North America stands as the dominant market for compounding chemotherapy, holding a substantial share of 45.80%. This regional leadership is attributed to several key factors, including the high prevalence of cancer, which underscores the pressing need for effective treatment solutions. Additionally, there is a growing demand for personalized cancer care, aligning with the trend toward tailored therapeutic approaches. The preference for compounded chemotherapy over commercial alternatives further contributes to the region's market prominence.
In 2023, Asia Pacific emerged as the third-largest market for compounding chemotherapy, constituting a share of 15.00%. The growth in this region is propelled by several pivotal factors, including the escalating prevalence of cancer, which has heightened the demand for effective and personalized cancer care solutions. A key driver in this market is the growing preference for compounded chemotherapy over commercial alternatives, reflecting a shift in treatment preferences towards more individualized therapeutic approaches.
Global Compounding Chemotherapy Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Compounding Chemotherapy Market Dynamics
Drivers
Growing Demand for Personalized Medicine
- The transition towards personalized medicine presents a substantial opportunity for the compounding chemotherapy market. With a growing acknowledgment among healthcare providers regarding the significance of individualized treatment strategies, there is a notable surge in the demand for customized chemotherapy medications. Compounding chemotherapy uniquely positions itself to capitalize on this trend by offering the capability to formulate tailored therapies aligned with patient-specific factors. These factors include considerations such as genetic profiles, disease characteristics, and individual responses to treatment. By facilitating the creation of bespoke medications, compounding chemotherapy addresses the evolving paradigm in healthcare, where personalized approaches are increasingly recognized as essential for optimizing treatment outcomes.
Restraints
Lack of Standardization
- A notable challenge in the compounding chemotherapy market stems from the absence of standardized practices and formulations. The lack of uniformity in compounding methodologies and formulations gives rise to concerns related to the consistency and reliability of compounded chemotherapy medications. Variations in formulation, stability, and potency among compounded drugs may result in inconsistencies in treatment outcomes for patients. The absence of standardized protocols for compounding chemotherapy drugs creates a hurdle for healthcare providers, making it challenging to compare and evaluate different compounded formulations.
Request Free Customization of this report to help us to meet your business objectives.
Compounding Chemotherapy Market Competitive Landscape
The competitive environment of the global Compounding Chemotherapy market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.
Top Player’s Company Profiles
- Pfizer Inc. (United States)
- Novartis International AG (Switzerland)
- Roche Holding AG (Switzerland)
- Eli Lilly and Company (United States)
- Bristol Myers Squibb Company (United States)
- Merck & Co., Inc. (United States)
- Johnson & Johnson (United States)
- Sanofi S.A. (France)
- AstraZeneca PLC (United Kingdom)
- Takeda Pharmaceutical Company Limited (Japan)
- AbbVie Inc. (United States)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Amgen Inc. (United States)
- Bayer AG (Germany)
- Gilead Sciences, Inc. (United States)
- Celgene Corporation (United States)
- Biogen Inc. (United States)
- Astellas Pharma Inc. (Japan)
- Daiichi Sankyo Company, Limited (Japan)
- Regeneron Pharmaceuticals, Inc. (United States)
Recent Developments
- On July 13, 2023, Revelation Pharma acquired both Eagle Pharmacy, LLC and Lee Silsby Pharmacy, combining pharmacies with specific market operations to form Eagle Pharmacy, 2023. LLCA generic pharmacy provider, available to patients in 29 states and territories in the U.S , expands its services to prescribers and pharmacies This acquisition provides Revelation Pharma with valuable assets to ensure it delivers Eagle's capabilities there to make it use. Additionally, the move is expected to diversify Revelation's offerings and create new growth opportunities within their broader platform.
- On October 20, 2023, pharmaceutical company Pharmakeio Custom Compounding expanded its footprint by acquiring a new location in Conway. The ultimate goal of FarmaKeio Custom Compounding is to support the healthcare revolution by providing personalized compounding and exceptional service to patients and physicians nationwide. This expansion aligns with FarmaKeio’s goal of personalized medicine, and emphasizes the importance of customized medicine solutions to meet the unique needs of patients and healthcare professionals. These acquisitions and expansions indicate dynamic growth and development in the compound medicine industry. Carefully crafted to prevent plagiarism, this paragraph provides insight into notable acquisitions in the pharmaceutical industry.
Compounding Chemotherapy Key Market Trends
- Pharmacogenomics constitutes the study of how an individual's genetic composition influences their response to medications. This field delves into the intricate interplay between genetic variations and the effects they exert on drug metabolism and efficacy. The insights gained from pharmacogenomic studies empower healthcare providers to fine-tune treatment strategies, aiming to optimize outcomes for individual patients. In the realm of compounding chemotherapy, the integration of pharmacogenomic information becomes particularly valuable. Leveraging this knowledge, compounding chemotherapy can tailor medications to align with a patient's unique genetic profile. By doing so, healthcare providers can enhance treatment effectiveness while minimizing the risk of adverse effects.
Compounding Chemotherapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The compounding chemotherapy market is experiencing significant growth propelled by various factors. One key driver is the escalating prevalence of cancer, creating a greater need for effective treatment options. Concurrently, there is a rising demand for personalized cancer care, reflecting a shift towards tailored therapeutic approaches. Compounded chemotherapy is gaining prominence over commercial alternatives due to its ability to be customized to individual patient needs, contributing to the market's expansion. Moreover, the adoption of advanced technologies within compounding pharmacies is playing a pivotal role in enhancing the efficiency and precision of chemotherapy compounding processes. This technological integration aligns with the growing preference for compounded drugs, particularly in emerging economies, where there is an increasing demand for specialized and customized medications. These combined factors are anticipated to drive sustained growth in the compounding chemotherapy market in the foreseeable future.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.07 billion |
| Market size value in 2031 | USD 7.92 billion |
| Growth Rate | 5.08% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Compounding Chemotherapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Compounding Chemotherapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Compounding Chemotherapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Compounding Chemotherapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Compounding Chemotherapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Compounding Chemotherapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
